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ABSTRACT 
 Since the development of gene therapy, a variety of non-viral nucleic acid delivery vehicles 
have been prepared and studied for their transfection efficiencies. Recently, polymeric gene 
delivery vehicles have gained popularity for their low immunogenicity and high transfection 
efficiency. With the advent of controlled radical polymerization (CRP) and more specifically 
reversible addition-fragmentation chain transfer (RAFT) polymerization, it is now possible to 
develop well-defined polymers with predicted molecular weights and architectures. The work 
presented here focuses on the RAFT polymerization of a family of amphiphilic, cationic 
copolymers to be utilized for nucleic acid delivery. These copolymers are composed of a 
stabilizing hydrophilic block of oligo(ethylene glycol) methyl ether methacrylate (OEMGA) and 
a cationic, endosomolytic block of 2-(dimethylamino) ethyl methacrylate (DMAEMA), 2-
(diethylamino) ethyl methacrylate (DEAEMA), or 2-(diisopropylamino) ethyl methacrylate 
(DPAEMA). The hydrophilic content of this copolymer series was kept constant while the degrees 
of polymerization of the cationic block of 25, 50, and 75 were targeted to elucidate the effects of 
tertiary amine functionalization on gene delivery efficacy. Means of characterization included gel 
permeation chromatography (GPC), dynamic light scattering (DLS), electrophoresis, and in vitro 
gene expression and toxicity studies. As a result from this study, our findings indicate the 
significance of cationic group functionalization on siRNA delivery, and the pH-responsive nucleic 
acid delivery vehicles synthesized show promise for future studies of nucleic acid delivery.   
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CHAPTER 1 
POLYMERIZATION METHODS 
By definition, a polymer is type of macromolecule containing a long sequence of repeating 
subunits; to create such molecules, a chemical synthesis or polymerization must be performed.  
Polymers, as a general term, can be subdivided into two broad categories, namely, naturally 
existing polymers such as DNA and proteins as well as synthetic polymers such as plastics, 
rubbers, and some pharmaceuticals.1 Since polymers have such a wide range of uses in various 
industries, it is important to gain a deeper understanding of the potential characteristics and 
properties made possible by the numerous polymerization techniques.   
 
1.1 Introduction to Polymers 
Much like the characterization of small molecules, polymers can be categorized by their 
chemical composition as well as their structural arrangement. Polymers are classified as either a 
homopolymer or a copolymer. A homopolymer contains only a single type of repeat unit or 
monomer molecule. Plastics such as polyethylene and polypropylene are examples of such 
homopolymers. Copolymers on the other hand are made up of two or more different species or 
types of repeat units. Our DNA is an example of a naturally occurring copolymer while butyl 
rubber, as found in the inner lining of tires, is a synthetic copolymer. Copolymers can then be 
further subdivided by the arrangement of the different monomer species within the polymer.1 
Examples of homopolymer and copolymer arrangements can be found in Figure 1.1.   
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Figure 1.1 Homopolymer and copolymer architectures. Illustrated copolymer structures are AB 
statistical, AB alternating, AB diblock, AB graft, ABA triblock, and ABC triblock. 
 
It is important to note that these different copolymer architectures can be used for a 
multitude of purposes in a variety of industries depending on the properties desired for the polymer 
and the application. Statistical and alternating copolymers exhibit properties that are intermediate 
of the corresponding homopolymers while block and graft copolymers generally exhibit full 
characteristics of each of the homopolymer blocks.1 Polymers, therefore, can be synthesized with 
essentially any collection of physical properties depending on the monomer units and copolymer 
structure.  
The properties of a polymer can also be affected by the size or length of the polymer chain; 
therefore, it is imperative to characterize the polymer dimensions by the molecular weight or the 
related degree of polymerization. Polymers, unlike small molecules, have a distribution of 
molecular weights. This distribution can be defined by either the number-average molecular 
weight (?̅?n) or the weight-average molecular weight (?̅?w) as shown in Equations 1.1 and 1.2 
respectively. 
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?̅?n  =  Σ XiMi  =  
Σ NiMi
Σ Ni
                                                 (Eq. 1.1) 
?̅?w  =  Σ wiMi  =   
Σ NiMi
2
Σ NiMi
                                           (Eq. 1.2) 
As defined in Equation 1.1, the number-average molar mass is the sum of the products of 
a molecule’s molar mass (Mi), and the mole fraction (Xi) of that particular molar mass in the 
polymer sample. Similarly as defined in Equation 1.2, the weight-average molecular weight is the 
sum of the molecules with weight fraction (wi) in the polymer multiplied by the molar mass of the 
molecules in this weight fraction. The ratio of these two values, ?̅?w/?̅?n, is known as the 
polydispersity index (PDI) which indicates the width of the molar mass distribution and gives 
insight into the range of molecular weights of a given polymer. Should the PDI near unity, the 
polymer would be considered monodisperse meaning that all of the polymers are of roughly the 
same length and molecular weight.1 To quantify the number of repeat units of a given species with 
the polymer structure, the degree of polymerization is calculated by dividing the molecular weight 
of the polymer by the repeat unit molecular weight as shown in Equation 1.3.  
?̅?n  =  
?̅?𝑛   
𝑀0
                                                        (Eq. 1.3)                                   
 
1.2 Polymerization Principles 
To create a polymer, as briefly mentioned, a series of reactions must occur to chemically 
link a number of monomer units together. For this process to be possible, the monomer molecules 
must have a functionality of two or more. In other words, the monomer must be capable of reacting 
with at least two other monomers so to form a link of monomer units which ultimately leads to the 
formation of a polymer. Considering that there are many varieties of chemical reactions and 
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polymerization methods with even more monomer molecules available, it is best to categorize 
polymerization reactions into two categories: step-growth polymerization and chain-growth 
polymerization.1 A generalized schematic for both of these polymerization methods is illustrated 
in Table 1.1.  
 
Table 1.1 Schematic for step-growth and chain-growth polymerizations (o: monomer repeat unit, 
I: initiator species). 
 Step-Growth Chain-Growth 
Dimer o + o → o-o 
I + o → I-o 
I-o + o → I-o-o 
Trimer o-o + o → o-o-o I-o-o + o → I-o-o-o 
Tetramer 
o-o-o + o → o-o-o-o 
o-o + o-o → o-o-o-o 
I-o-o-o + o → I-o-o-o-o 
Pentamer 
o-o-o-o + o → o-o-o-o-o 
o-o-o + o-o → o-o-o-o-o 
I-o-o-o-o + o → I-o-o-o-o-o 
 
 
For step growth polymerizations, reactions can occur between any two molecular species 
in the polymerization solution in order to grow the polymer chains. Though monomer molecules 
are consumed quickly during the early phases of the polymerization, the degree of polymerization 
increases throughout the reaction since two polymer chains can join to form one much larger 
polymer chain. One negative aspect of this polymerization method though is that it is not ideal for 
synthesizing large molecular weight polymers. Since the monomers are consumed early in the 
reaction, only polymer chains are available to move around in solution and react with each other 
to form the larger polymer chains. Even moderately long polymer chains do not move well in 
solution since steric hindrance affects the range of motion and molecular diffusion. This loss of 
mobility means large molecular weight polymers are more difficult to synthesize by step growth 
polymerization.1 
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On the other hand in chain-growth polymerizations, monomer molecules are consumed 
throughout the entire polymerization reaction, and larger molecular weight polymers with high 
degrees of polymerization are possible. Once polymerization has been initiated, the chain growth 
occurs very rapidly with successive additions of monomer molecules to the growing polymer 
chain. When the polymer chain becomes terminated, it is no longer able to propagate, and the 
overall degree of polymerization does not change; however, the number of polymer chains formed 
increases.1 
 
1.3 Radical Polymerization 
Radical polymerizations, one type of chain grown polymerization, are the most widely used 
polymerization method to date and are known for their versatility to utilize a wide range of 
unsaturated monomers. The polymer grows by the reaction between an unsaturated molecule and 
a molecule containing a free radical as shown in Scheme 1.1. Being a type of chain growth 
polymerization, propagation during a radical polymerization occurs by the sequential additions of 
monomer units to the radical reactive site otherwise known as the active center. For all radical 
polymerizations, the free radical on the end of the chain attacks a monomer causing homolytic 
cleavage of the π-bond. One electron from this broken π-bond forms a new covalent bond between 
the two molecules, and the lone, free electron then moves to the terminal carbon atom creating a 
new active center.1 
 
Scheme 1.1 Radical polymerization mechanism. The polymer growth is indicated by sequential 
addition of an unsaturated molecule to the active center to create a new active center. 
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Radical polymerizations can be further divided into two main categories: conventional free 
radical polymerization and controlled radical polymerization (CRP). These two categories mainly 
differ by the amount of time that the free, active radicals are present during the polymerization 
process. For free radical polymerizations, the radical sites are active for most of the time during 
the polymerization; however, for CRP, the radical sites are only active for short bursts of time. The 
CRP techniques afford better control over the resulting polymers as much research has been 
completed in this area since their development in the 1990s.1 
 
1.4 Controlled Radical Polymerization 
 For reversible-deactivation polymerizations the radical sites are only active for a short 
amount of time since they are temporarily deactivated throughout the polymerization by being 
reversibly trapped by another molecular species. The CRP techniques, utilizing the reversible-
deactivation strategy, work to limit termination events resulting in the polymerization techniques 
maintaining most of the active sites throughout the polymerization. If all of the polymer chains 
can be initiated at the same time, the end result yields a polymer with a PDI close to one.1 This 
living quality of the CRP methods makes them very valuable in a number of industries such as 
pharmaceutics.2-4  
There are two documented mechanisms to gain the pseudo-living quality of the CRP 
methods. The first strategy involves a reversible end-capping process as shown in Figure 1.2a. 
Here, a chain-capping species (denoted R) reversible reacts with a propagating radical chain. The 
polymer can only grow when species R is not bound to the radical chain, and it ceases propagation 
when the chain-capping species is bound. The second CRP strategy utilizes a degenerative chain 
transfer mechanism as illustrated in Figure 1.2b. This strategy relies on a chain transfer reaction in 
7 
 
which a free radical chain displaces the non-radical chain causing a transfer of the active species 
from one chain to another. Both the reversible end-capping and degenerative chain transfer 
strategies must include a rapid, reversible exchange of the active species to ensure that each 
polymer chain grows with the same probability. Also, due to the temporary deactivation of radical 
species throughout the polymerization that results in low radical concentrations, termination events 
for both strategies are almost completely suppressed1.  
 
(a) Reversible end-capping 
 
 
 
 
(b) Degenerative chain transfer  
 
 
 
 
 
 
Figure 1.2 Controlled radical polymerization strategies: (a) reversible end-capping method and 
(b) the degenerative chain-transfer strategy. 
 
 
There are three main types of CRP methods: nitroxide mediated radical polymerization 
(NMP), atom transfer radical polymerization (ATRP), and reversible addition-fragmentation chain 
transfer (RAFT) radical polymerization. Both NMP and ATRP utilize the reversible end-capping 
strategy while RAFT utilizes the degenerative chain-transfer mechanism. Briefly, NMP employs 
nitroxide radicals as the end-capping group while ATRP utilizes a transition metal-halide 
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complex.1 RAFT, on the other hand, utilizes a chain transfer agent (CTA) to mediate the 
degenerative chain transfer process.1-2, 5-6  
 
1.5 RAFT Polymerization 
 Reversible addition-fragmentation chain transfer (RAFT) polymerization was first reported 
in 1998 by the Commonwealth Scientific and Industrial Research Organization (CSIRO) in 
Australia.5-6 Independently, a French research group led by Bouhadir patented the same process 
under the name Macromolecular Design via the Interchange of Xanthates (MADIX).8-9 Though 
the names differ, both polymerization methods are dependent on a degenerative chain transfer 
process utilizing a controlling agent for polymer synthesis. Since its invention, RAFT has become 
one of the most widely used polymerization methods because of the variety of tolerable functional 
monomers available and because it creates near monodisperse polymers of well-defined molecular 
weight and architecture.2  
 
1.5.1 RAFT Mechanism 
 The RAFT polymerization mechanism, as illustrated in Scheme 1.2, utilizes a 
thiocarbonylthio CTA to support the living polymerization characteristics associated with the 
controlled radical polymerization methods. The main stages of RAFT polymerization are the 
initiation or generation of radicals, activation of the CTA, propagation of polymers, and 
termination of the polymer chains.1-2, 10   
 To initiate RAFT polymerizations, primary radicals must be generated as with any 
traditional radical polymerization method (Scheme 1.2; Reaction 1); therefore, initiation processes 
utilizing energy sources such as heat, UV radiation, or gamma radiation may be employed. 
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Contrary to conventional radical polymerization methods, the primary radical species react with 
and activate the RAFT chain transfer agent.1-2, 10 Some common thermal initiators are shown in 
Figure 1.3. 4, 10  
 
Scheme 1.2 RAFT polymerization mechanism. Reaction steps include (1) radical initiation of the 
initiator species utilizing heat or radiation, (2, 3) CTA activation by a radical species and pre-
equilibrium with formation of oligomers, (4) main equilibrium of the RAFT polymerization with 
propagating polymer chains, and (5) termination of polymer chains. 
 
 
 
10 
 
 
Figure 1.3 Common thermal initiators. 
 
Once there are radical species in solution, the activation of the RAFT agent can occur by 
one of two different mechanisms (Scheme 1.2, Reactions 2 and 3). Since the monomer 
concentration is much larger than the CTA concentration, the primary radical has a higher 
probability of activating a monomer molecule over a RAFT agent (Scheme 1.2, Reaction 2). The 
activated monomer species can then react with either other monomer units or the RAFT agent. 
Considering the high chain transfer constant of the CTA, it is unlikely that many monomers will 
react with the activated monomer before reacting with a CTA. Once the CTA has been activated 
forming the intermediate species, the fragmentation process occurs when the leaving group 
homolytically cleaves and is now able to react with monomers in solution. In order to ensure this 
R group fragmentation, it is advantageous to choose a CTA in which the R group is a better free 
radical leaving group than the activated monomer. Alternatively, the primary radical may directly 
react with the CTA forming the intermediate radical (Scheme 1.2, Reaction 3). Again, the 
fragmentation process occurs, and the leaving R group can now propagate in solution by reacting 
with monomer molecules.1-2, 10  
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It is important at this time to note the ratios of the polymerization mixture in order to make 
the kinetics of this pre-equilibrium step, as well as the overall RAFT mechanism, more apparent. 
Ideally, there will be a CTA to initiator ratio ranging from 2:1 to 10:1. The CTA controls the 
number of polymer chains while the initiator dictates the number of free radicals in the system. 
Since the initial initiator concentration is much less than the initial CTA concentration, there will 
be more dormant polymers in the system than activated polymer chains. The pre-equilibrium stage 
encompasses the activation of the RAFT agents and the beginning of polymer formation in which 
only oligomers are formed.2, 10 After all of the CTAs have been activated, the polymerization 
moves into the main equilibrium stage in which the bulk of the monomer molecules are consumed. 
It is this point in the polymerization that the living characteristics become apparent (Scheme 1.2, 
Reaction 4). Here, the CTAs undergo the degenerative chain transfer process between polymer 
chains with only the radical species propagating in solution while the thiocarbonylthio species 
remains dormant.1-2 
For termination of the polymerization to occur, a few situations are possible. The reaction 
can go to completion to the point where there are no more monomer molecules in solution able to 
react with propagating polymer chains. The reaction mixture can also be introduced to an 
atmosphere containing a high concentration of radical species such as oxygen. Bimolecular 
reactions in which two radical chains undergo a combination or disproportionation termination 
process ultimately leading to a dead polymer are also possible. Once the polymer chains are 
inactive from a termination process, they can no longer propagate and the polymerization is 
complete.10   
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1.5.2 RAFT Chain Transfer Agent (CTA) 
The chain transfer agent is imperative to the RAFT polymerization process in order to 
successfully achieve the desired living conditions; therefore, the CTA must be carefully chosen 
for each RAFT polymerization. A wide variety of thiocarbonylthio RAFT agents with the general 
structure RSC(=S)Z have been identified and reported in the literature. Figure 1.4 illustrates the 
four subcategories of the thiocarbonylthio structural family including dithioesters, xanthates, 
dithiocarbamates, and trithiocarbonates. An effective RAFT agent must have a reactive carbon-
sulfur double bond (C=S) and result in a radical that can reinitiate the polymerization process. The 
CTA must also give an intermediate radical that favors the elimination of the free radical leaving 
group. Some commonly used RAFT agents are illustrated in Figure 1.5. 2, 4, 10 
 
 
When choosing a CTA for the desired polymerization, it is imperative to recognize how 
the CTA will interact with the monomer and resulting polymer chains. These interactions are what 
ultimately affecting the RAFT polymerization kinetics.4, 10 Figure 1.6 illustrates the structures of 
a dithioester RAFT agent throughout the polymerization process.2 Compound (1) includes the 
reactive C=S double bond as well as a Z group capable of activating this double bond.10-11 The 
intermediate radical illustrated by compound (2) includes two free radical leaving groups, R and 
R’. For this CTA to be effective, the R group must contain a weaker single bond capable of 
fragmenting from the CTA intermediate. Also, the Z group ensures stabilization for the duration 
Dithioester                  Xanthate Dithiocarbamate                  Trithiocarbonate                
Figure 1.4 General structure of the RAFT chain transfer agents. 
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of the equilibrium. Finally, once the R group has fragmented and is a free radical in solution, it 
must be capable of reinitiating polymerization. Then the addition-fragmentation chain transfer 
mechanism occurs in the opposite direction to develop a new propagating radical thus moving the 
polymerization process into the main equilibrium.2, 10 
 
 
Figure 1.5 Commonly used chain transfer agents in RAFT polymerization. 
 
 
 
 
 
Figure 1.6 CTA structures during RAFT polymerization 
 
1.5.3 Molecular Weight Control 
 RAFT polymerization is well known for its control over the polymer molecular weight. 
The innate living conditions provided by the RAFT agent in part allows for this regulation over 
CTP                CMP              
CDP                DMP                
BDB                CDB                
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the molecular weight; however, there are other conditions that must be met to afford the desired 
control. The two main sources of polymer chains during the RAFT polymerization process are the 
radical initiator fragments formed from homolytic cleavage of the initiator as well as the radical 
CTA leaving groups formed from the CTA fragmentation step. Taking these radical sources into 
consideration, the equation for the theoretical number-average molecular weight (𝑀𝑛,𝑡ℎ) from a 
RAFT polymerization is given in Equation 1.4.   
Mn,th =   
[𝑀]0𝑀𝑀𝑊𝜌
[𝐶𝑇𝐴]0+2𝑓[𝐼]0(1−𝑒
𝑘𝑑𝑡)
 + CTAMW                            Eq. 1.4 
 
 
 
 
 
 
 From the denominator of Equation 1.4, it can be determined that the CTA to initiator 
concentration plays a role in the control of the polymer molecular weight. Should the ratio of 
[CTA]0:[I]0 be sufficiently high, the fraction of polymer chains initiated from radical initiator 
fragments will be less than 5% of the overall polymer chain sources7; therefore, the initiator term 
in the denominator can typically be ignored, and Equation 1.4 can be simplified to Equation 1.5.  
 
Mn,th =  
[𝑀]0𝑀𝑀𝑊𝜌
[𝐶𝑇𝐴]0
 + CTAMW                                      Eq. 1.5 
 
This equation now clearly indicates a linear relationship between polymer number-average 
molecular weight and monomer conversion (ρ); therefore, after analysis of experimental kinetic 
[M]0    initial monomer concentration 
MMW  monomer molecular weight    
ρ  monomer conversion 
[CTA]0 initial CTA concentration         
f  initiator efficiency 
[I]0  initial initiator concentration 
kd  initiator decomposition rate constant 
CTAMW    CTA molecular weight 
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data of the desired RAFT polymerization, polymers of a predetermined molecular weights and 
narrow polydispersity can be produced.10  
 
1.5.4  Block Copolymer Synthesis 
 Block copolymers have a wide range of applications since they express characteristics of 
the homopolymer components as well as properties resulting from homopolymer linking. RAFT 
polymerization is a powerful method for the development of complex polymer architectures, and 
it is commonly employed for the synthesis of block copolymers.1-2 Polymers synthesized via 
RAFT polymerization contain a thiocarbonylthio end group in the polymer structure. This 
polymer, now termed the macro chain transfer agent (macroCTA), reacts similarly to the low 
molecular weight CTA utilized for developing homopolymers, and it can be chain extended with 
another monomer species to form the desired AB diblock copolymer.2 The generalized RAFT 
synthesis of diblock copolymers is illustrated in Figure 1.7. 
 
Figure 1.7 General mechanism for the RAFT synthesis of diblock copolymers 
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 Much like homopolymer synthesis, after initiation the propagating polymer chain will 
undergo addition to the macroCTA by attacking the π-bond of the thiocarbonylthio end group. The 
originally dormant polymer will then preferentially fragment from the intermediate species 
resulting in a new active polymer capable of chain extending with the second monomer species. 
The originally active polymer is now dormant with the thiocarbonylthio end group.1-2  
 Polymer sources during diblock copolymer synthesis originate from the radical initiator 
fragments from the original initiation step and the polymer radicals that have fragmented from the 
macroCTA intermediate compound.  Knowing these polymer chain sources, the block copolymer 
molecular weight can be calculated similarly to that of a homopolymer as denoted in Equation 1.6 
with the percentage of dead polymer chains defined in Equation 1.7.2  
 
Mblock copolymer = 
[𝑀]0𝑀𝑀𝑊𝜌
[macroCTA]0+2𝑓[𝐼]0(1−𝑒
𝑘𝑑𝑡)
 + MmacroCTA                     (Eq. 1.6) 
 
 
 
 
 
 
 
% dead chains = 
2𝑓[𝐼]0(1−𝑒
𝑘𝑑𝑡)
[macroCTA]0+2𝑓[𝐼]0(1−𝑒
𝑘𝑑𝑡)
                      (Eq. 1.7) 
 
It can be inferred that a high [macroCTA]0:[I]0 ratio indicates that the majority of the 
polymer chains are generated from the macroCTA; therefore, the molecular weight calculation for 
a block copolymer can be simplified to Equation 1.8 by neglecting the initiator terms. A linear 
[M]0    initial monomer concentration 
MMW   monomer molecular weight    
ρ   monomer conversion 
[macroCTA]0  initial macroCTA concentration         
f   initiator efficiency 
[I]0   initial initiator concentration 
kd   initiator decomposition rate constant 
MmacroCTA     macroCTA molecular weight 
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relationship between block copolymer molecular weight and monomer conversion can now be 
observed, and the polymerization kinetics can be somewhat predicted to produce polymers of well-
defined molecular weight and architecture. The high [macroCTA]0:[I]0 ratio also indicates an 
inverse relationship between dead polymer chains and initial macroCTA concentration; therefore, 
having a higher concentration of macroCTA in the polymerization solution would cause most of 
the polymer chains to remain in the main equilibrium stage of RAFT polymerization resulting in 
a polymer of low molecular weight dispersity.  
 
Mblock copolymer = 
[𝑀]0𝑀𝑀𝑊𝜌
[macroCTA]0
 + MmacroCTA                                                (Eq. 1.8) 
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CHAPTER 2 
GENE DELIVERY 
 Gene therapy is a novel approach to replacing or modifying the use of drugs or other 
therapies that treat symptoms in patients.12 This therapeutic method utilizes a gene delivery vehicle 
to transport genetic material into affected cells in order to alter expression of existing genes, 
supplement existing proteins, or induce cytotoxic activity. Though the first gene therapy trials 
began in 1990, it wasn’t until the year 2000 that the first successful gene therapy treatment was 
reported. With this success came an increased interest in the development of gene therapies, 
lending to the pursuit of a safe and effective gene delivery vehicle for clinical use.13 
Both viral and non-viral gene delivery vehicles have been studied and characterized for 
their gene delivery efficiencies. The production of non-viral vehicles has gained much more 
attention, however, since viral vectors tend to induce an immunogenic response and are considered 
toxic to cells.14-15 The two categories of non-viral vehicles studied are natural polymers such as 
chains of amino acids and synthetic polymers (usually cationic) with the majority of the research 
focused on developing new synthetic polymers. One major limitation with these gene delivery 
vehicles though is that their molecular interactions with cells are poorly understood adding a layer 
of complexity to the development of efficient delivery vehicles.3 Some barriers to successful 
nucleic acid delivery include cellular uptake, endosomal escape, and delivery efficiency of genetic 
material to the nucleus; therefore, polymers must be produced to overcome these known barriers 
so gene therapies can move forward in development.3, 14-15
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2.1 Gene Delivery Mechanism 
Though the full delivery mechanism and corresponding cellular interactions are not 
completely understood, the known barriers can be applied to the accepted gene delivery 
mechanism as illustrated in Figure 2.1. In order to produce efficient polymeric gene delivery 
vehicles, it is imperative to develop an understanding of this delivery mechanism.  
 
 
The first step to gene delivery is the complexation of the delivery vehicle with the genetic 
material. Synthetic, cationic polymers are attracted to the negatively charged phosphate backbone 
of the genetic material by electrostatic interactions. The polymer and genetic material, once 
complexed, are termed a polyplex.16 This polyplex, having an overall positive charge, is attracted 
to the negatively charged phospholipid bilayer of the cell exterior, again by electrostatic 
interactions. The polyplex then enters the cells by means of endocytosis. Once inside the cell, the 
genetic material and polymer are released into the cytoplasm leaving the genetic material to enter 
the nucleus and affect the cell17; the means of intracellular release, however, is under debate.  
Figure 2.1 Mechanism for the delivery of genetic material by means of cationic polymer. 
Polymer and genetic material combine by electrostatic interactions, enter the cell by 
endocytosis, release into the cytoplasm, and the genetic material enters the nucleus. 
Cationic  
Polymer 
Genetic 
Material 
Polyplex 
Formation 
Endocytosis Release Nucleus 
Entry 
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2.1.1 Proton Sponge Effect 
 There are multiple theories used to explain the endosomal escape pathway once the 
polyplex is taken up by the cell. One theory, termed the proton sponge effect, is illustrated in Figure 
2.2. After endocytosis, the polyplex resides in an endosome which is known to facilitate 
degradation of foreign material; therefore, in order for the gene delivery vehicle to transport the 
genetic material to the nucleus, it must induce an endosomal escape mechanism.17 To degrade 
foreign material, the endosome utilizes an ATPase proton pump enzyme to decrease the internal 
pH to acidic values of pH 5-6 moving it into the late endosomal stage. It then further traffics the 
material to a lysosome which has an even lower pH value of approximately 4.5.17 Once the 
trafficking mechanism reaches this point, the polymer and genetic material cannot escape to the 
cytoplasm and are degraded. To overcome this endosomal trafficking and degradation, the gene 
delivery vehicle can be designed with cationic polymers of a desired pKa value. Should the cationic 
polymer have a large number of titratable side chains, namely in the form of secondary or tertiary 
amines, the pKa value can be tapered between the physiological pH and the pH of a lysosome. 
Once this cationic polymer enters the endosome, it will induce a larger influx of protons in order 
to protonate the amine groups.  With this larger proton influx, comes a larger counter ion influx of 
chloride ions which then induces a larger intake of water molecules to compensate for the increased 
ion concentrations. It is this increase in water concentration that increases the osmotic pressure of 
the endosome eventually reaching a maximum point causing the endosome to burst. Once the 
endosome bursts, the genetic material is free in the cytoplasm to travel to the nucleus and obtain 
the desired biological activity.17-19 
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2.2 Previous Studies 
 In order to take advantage of the endosomal escape mechanism by means of the proton 
sponge effect, certain cationic polymers have been extensively studied. Poly(ethyleneimine) (PEI), 
in particular, is known as the gold standard of cationic gene delivery vehicles since it has been 
reported to have high efficiency of polyplex formation as well as high gene expression15, 20; 
however, this purely cationic polymer induces immunogenic responses both in vitro and in vivo 
because of it nonspecific interactions with proteins and cells.14-15, 21 Another limitation with 
utilizing cationic polymers such as PEI includes the lack of control over the molecular weight and 
architecture of the resulting polymers. Knowing these limitations, there is an inherent need to 
develop polymers with a hydrophilic section to impart polyplex stability and decrease cell toxicity 
as well as a need to develop or utilize a polymerization method that would afford control over the 
polymer synthesis in order to create polymers of well-defined molecular weights and architectures.  
 
 
Nucleus 
Entry 
Release Endosomal 
Burst 
Osmotic Pressure 
Increase 
Figure 2.2 Mechanism for endosomal release as described by the proton sponge hypothesis. 
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2.2.1 RAFT and Gene Delivery 
 With the advent of controlled radical polymerization (CRP), and more specifically RAFT 
polymerization, control over the synthesis of well-defined molecular weight polymers is now 
possible. Since the initial report on RAFT polymerization in 1998, many advances in the 
development of gene therapies have occurred. One significant adaptation of RAFT polymerization 
allowing for these advances is the ability to produce water-soluble, functional polymers, allowing 
not only the molecular weights and architectures of the polymers to be controlled, but 
biocompatibility of the polymer can also be afforded making RAFT polymerization ideal for 
developing gene delivery vehicles.3-4, 10 A brief summary of the more common hydrophilic and 
pH-responsive monomers polymerized by RAFT and used for gene delivery purposes is shown in 
Figure 2.3 and Figure 2.4 respectively.3, 10 
  In the sections to follow, a number of previous works will be discussed. These publications 
report their findings on the RAFT synthesis of “smart” gene delivery vehicles. These copolymers 
are considered smart in that they contain a cationic moiety with a pKa range around that of 
physiological conditions; therefore, they will respond to the pH gradient present in the endosomal 
pathway and induce the proton sponge effect. The first studies to be discussed will elucidate the 
effects of the addition and structural manipulation of the hydrophilic content to the gene delivery 
vehicle22-24 while the remainder of this chapter will focus on varying the endosomolytic block to 
deduce their effects on the nucleic acid delivery efficiency.28-31  
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Figure 2.3 Hydrophilic monomers polymerized by RAFT for use in gene delivery vehicles. 
Oligo(ethylene glycol) methyl ether methacrylate (OEMGA), N-Isopropylacrylamide (NIPAM), 
Butyl methacrylate (BMA), 2-Hydroxyethyl methacrylate (HEMA), and 3-Hydroxypropyl 
methacrylamide (HPMA) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4 pH-responsive monomers polymerized by RAFT for use in gene delivery vehicles. 2-
Dimethylaminoethyl methacrylate (DMAEMA), 2-Diethylaminoethyl methacrylate (DEAEMA), 
2-Diisopropylaminoethyl methacrylate (DPAEMA), 4-Vinyl pyridine (4VP), and Acrylic acid 
(AA) 
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2.2.2 Hydrophilic Architecture 
 PEI, though the gold standard for gene delivery, is known to induce an immunogenic 
response as a result of its nonspecific interactions with cells and proteins. In order to overcome 
this toxicity, it has been proposed to conjugate the cationic polymer with a hydrophilic, 
biocompatible polymer.3, 14-15, 22-24 This hydrophilic segment then increases polyplex stability in 
physiological conditions as well as decreases cell toxicity making cationic polymers a more tenable 
for gene therapy use. One common way of improving the biocompatibility of the polymer is to 
incorporate poly(ethylene glycol) (PEG) into the copolymer design, eventually coining the term 
PEGylated copolymer.22-24   
In 2002 and 2004, Deshpande et al. reported findings on PEGylated cationic copolymers 
containing the tertiary amine functionalized monomer 2-(dimethylamino) ethyl methacrylate 
(DMAEMA).22-23 For this study the topology of the hydrophilic block was modified to elucidate 
its effect on gene delivery. Three different hydrophilic architectures were developed for this study 
by chain extending DMAEMA with different PEG-containing molecules as outlined in Table 2.1. 
Being linear in its natural state, PEG was utilized to develop a linear diblock copolymer as 
illustrated in Figure 2.5a. Two different PEG-functionalized polymers were then used to produce 
brush and comb-type copolymer structures. Poly(oligo(ethylene glycol) methyl ether 
methacrylate) (OEGMA) containing 7-8 PEG repeat units as side chains composed the hydrophilic 
content of the brush diblock copolymer (Figure 2.5b) while poly(ethylene glycol) methyl ether 
methacrylate (PEGMA) having 45 ethylene glycol repeat units as side chains was employed for 
the comb-type statistical copolymer (Figure 2.5c). Though PEG is present for all copolymers in 
this study, the percentage of this hydrophilic polymer differs among the different architectures. 
Since PEGMA contain PEG side chains 45 ethylene glycol units long, the degree of polymerization 
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of PEGMA as reported gives the statistical copolymer a higher overall PEG content as compared 
to the two diblock copolymers which contain similar hydrophilic content. Interestingly, the 
statistical copolymer also contains a larger number of DMAEMA repeat units giving the 
copolymer more protonatable side chains as compared to the diblock copolymers. Once 
synthesized, the copolymers were then studied in vitro in order to characterize and determine their 
gene delivery efficiency and cell toxicity. Three different cell lines, namely COS-7, human A549, 
and HepG2 cells, were used for the in vitro studies. From these characterization experiments, it 
was revealed that modification of the PEG architecture does have an effect on the gene delivery 
efficacy. Deshpande et al. reported similar transfection efficiencies for both the brush and linear 
diblock copolymers across all cell lines with the exception of the brush copolymer in the A549 
cell line in which low gene expression was observed. The comb-type statistical copolymer, 
however, indicated low transfection efficiencies for all three cell lines. From a cytotoxic 
standpoint, the linear copolymer induced the most toxic effects resulting in the lowest cell viability 
of the copolymers studied; this polymer was also reported to have a concentration dependent 
toxicity with higher polymer concentration indicating lower cell viability. In contrast, both the 
block and statistical copolymers indicated similar high cell viability despite the polymer 
concentrations.22-23 
 
Table 2.1 Properties of tertiary amine methacrylate polymers by Deshpande et al.22-23; m denotes 
the cationic degree of polymerization and n denotes the PEG-containing moiety degree of 
polymerization 
Polymer Mn m n Mw/Mn 
DMAEMA 5130 32 - 1.18 
DMAEMA-OEGMA 8600 37 6-7 1.12 
DMAEMA-PEG 7800 37 45 1.25 
DMAEMA-stat-PEGMA 21000 66 5 1.11 
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Figure 2.5 Structures of tertiary amine methacrylate polymers by Deshpande et al.22-23 
 
  
 In 2011, a similar study by Venkataraman et al. was published and reported findings on 
DMAEMA PEGylated copolymers.24 For this study, the architecture of the hydrophilic block was 
again modified; however, the PEG weight fractions were similar among all polymers produced. 
The degree of polymerization of DMAEMA was also maintained to ensure the amount of cationic 
charge did not vary within the copolymer series. Like Deshpande, Venkataraman et al. aimed to 
define gene delivery efficiencies based solely on the topology of the PEG units.  Here, PEG and 
OEGMA were again utilized for the linear diblock and brush diblock configurations respectively; 
however, unlike Deshpande, OEGMA was also utilized for the statistical copolymer.  These 
hydrophilic polymers were then chain extended with DMAEMA to develop a series of PEGylated, 
cationic copolymers. In all, three copolymer structures were synthesized (Table 2.2). The 
generalized structure of these three polymers is outlined in Figure 2.6 while the synthesis 
illustrated in Scheme 2.1. After synthesis, the copolymers were then characterized in vitro to better 
understand their gene delivery efficiency and cell toxicity. Transfection experiments were carried 
out in both HEK293 and HepG2 cell lines to determine if the copolymer mediated transfection is 
cell type dependent. From these experiments, Venkataraman et al. also concluded that the PEG 
architecture has an effect on the gene delivery efficacy. Here, however, the reported trend indicated 
that the linear diblock copolymer induced higher gene expression as compared to the statistical 
(a) (b) (c) 
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and brush block copolymers in both cell lines utilized. Interestingly, a cell dependent transfection 
efficiency was observed for all polymers with lower expression levels in the HepG2 cells. Cell 
toxicity was also studied utilizing the same two cell lines as in the transfection experiments, and 
cell dependent toxicity levels were reported. HEK293 cells were noted to have higher cell viability 
as compared to the HepG2 cells. Similar viabilities were observed for all copolymer architectures 
in the HEK293 cells; however, the polymers except the statistical comb-type copolymer induced 
a toxic effect in the HepG2 cells.24 
 
Table 2.2 Characterization of compositionally equivalent and topologically different PEGylated 
cationic polymers by Venkataraman et al.24 
Copolymer ?̅?n  (Da) PEG weight 
fraction 
No. nitrogen 
atoms 
mPEG-b-p(DMAEMA) 10100 0.20 49 
p(DMAEMA-co-OEGMA)    
(a) 10700 0.24 46 
(b) 15000 0.22 67 
(c) 196000 0.23 90 
p(OEGMA)-b-p(DMAEMA) 11800 0.22 53 
 
 
 
 
 
 
Figure 2.6 Schematic representation of model PEGylated cationic polymers containing 
different architectures of equivalent PEG components (represented by blue line) and 
comparable cationic components (represented by gray lines with positive charges) by 
Venkataraman et al.24 
+ + + 
+ + 
+ 
+ + 
+ 
+ 
+ + 
+ + + 
+ + 
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Scheme 2.1 RAFT polymerization-based synthetic route for the compositionally equivalent and 
topologically different PEGylated poly(dimethylaminoethyl methacrylate) based macromolecules, 
where the architecture of PEG chains was systematically varied to result in diblock copolymer (2), 
statistical copolymer (3a-c) and brush-block copolymer (5) by Venkataraman et al.24 
 
   
 As a result of these studies, it was proposed that the architecture of the hydrophilic 
PEGylated content does have a significant effect on the transfection efficiencies of gene delivery 
vehicles. Though these works do disagree on overall trends indicated from transfection 
experiments, both authors conclude that the block topology, whether linear or brush-type, indicates 
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better nucleic acid delivery and gene expression than that of the statistical copolymer. As for cell 
viability, it was concluded that the copolymers have cell dependent toxic effects with the statistical 
copolymer inducing less of an immunogenic response as compared to the block topologies.22-24 
Additionally, it is worth noting that of the PEGylated molecules studied, only OEGMA and 
PEGMA can be synthesized with the polymerization control afforded by RAFT since they contain 
the needed reactive double bond. Therefore, moving forward, it would be advantageous to focus 
on utilizing OEGMA block copolymers for gene delivery purposes since these copolymers indicate 
low toxicity and high gene expression levels, and RAFT can be employed for synthesis purposes.   
 
2.3.3 pH-Responsive, Cationic Polymers 
 Since it has been determined that PEGylation of cationic polymers increases the 
biocompatibility of the gene delivery vehicle, it now becomes imperative to develop polymers 
capable of successfully escaping the endosome before degradation. To produce such polymers, it 
is advantageous to utilize pH-responsive monomers capable of capitalizing on the proton sponge 
effect. Monomers that are considered pH-responsive are those that take advantage of a changing 
pH environment by altering their degree of ionization depending on the pH of the surrounding 
solution.  For example, weak polyacids become more protonated by accepting protons at higher 
pH values while weak polybases become protonated at lower pH values. The actual ionic charge 
of the polyacids is negative at higher pH values while the opposite holds true for polybases in that 
they are positive at lower pH values.10 Since the genetic material has a negative charge, it would 
be advantageous to further develop gene delivery vehicles utilizing polybases as they hold a 
positive charge in the lower pH values present in endosomes.  
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 One type of pH-responsive monomer includes polybases containing a tertiary amine group. 
Of these tertiary amine containing monomers, DMAEMA has been the most extensively studied 
since the first reports of CRP and RAFT polymerization mainly due to its high transfection 
efficiencies and endosomal destabilizing properties.25-27 The following studies to be discussed will 
focus on the RAFT polymerizations utilizing tertiary amine-containing monomers such as 
DMAEMA to synthesize gene delivery vehicles. The overall goal of this section is to deduce 
effects on how changing components of the endosomolytic block influences transfection 
efficiencies and cell toxicity.  
 In 2012, Hinton et al. published their work on the RAFT polymerization of ABA triblock 
copolymers designed for gene delivery. The copolymers were composed of the hydrophilic, PEG-
functionalized monomer OEGMA (A-block) and the cationic DMAEMA monomer (B-block). 
Briefly, the DMAEMA macro chain transfer agent (macroCTA) was synthesized utilizing a bis-
RAFT agent capable of producing the triblock copolymer functionality. The DMAEMA 
macroCTA was then chain extended with OEGMA in one of two different methods. The first of 
which utilized the raw product of macroCTA synthesis; therefore, DMAEMA monomers were still 
in solution and capable of copolymerizing with the OEGMA producing statistical A-blocks. For 
the second method the macroCTA was purified before chain extension with OEGMA; therefore, 
the resulting A-blocks consisted of pure hydrophilic content. Once synthesized, the copolymers 
then were subject to a quarternization reaction so that the DMAEMA repeat units would carry a 
permanent positive charge despite changing pH. Table 2.3 outlines a summary of the polymers 
synthesized for this study while Scheme 2.2 illustrates the polymerization schematic. The naming 
scheme found in Table 2.3 indicates the triblock architecture ABA followed by the number of PEG 
monomers/number of DMAEMA repeat units; Q indicates a quasi tri-block as synthesized from 
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polymerization method 1 while P indicates a pure tri-block synthesized from polymerization 
method 2. The triblock copolymers were synthesized with various A and B block lengths with the 
ultimate goal to determine the most efficient and least toxic copolymer structure. To characterize 
the ABA triblock copolymers, Hinton et al. utilized CHO-GFP and HEK293 cells to elucidate the 
copolymer effect on cell toxicity while only CHO-GFP cells were employed for cellular uptake 
and gene silencing assays. Hinton et al. reported that of the cationic B-block lengths studied, the 
range of DMAEMA repeat units between 110 and 120 was ideal for cellular uptake across the 
range of cells studied. Additionally, it was noted that decreasing the cationic block length caused 
a decrease in cellular uptake while increasing it caused an increase in cytotoxicity. 
 
Table 2.3 The number average molecular weight, dispersity, and composition of the block 
copolymers prepared from DMAEMA and OEGMA475 using RAFT polymerization from Hinton 
et al.28 
ID* Polymerization 
Method 
Block B 
(PDMAEMA): 
molar mass 
(Mn in kDa)/ 
dispersitya 
Tri-block 
ABA: 
molar mass 
(Mn in kDa)/ 
dispersitya 
Number of 
repeat units 
in each 
block: 
A-B-Ab 
% of 
DMAEMA 
in A blocks 
ABA-7/38Q 1 6.8/1.12 13.8/1.13 7-38-7 2.7 
ABA-15/82Q 1 13.7/1.09 28.3/1.22 15-82-15 6.0 
ABA-58/108P 2 17.9/1.15 73.1/1.72 58-108-58 0.0 
ABA-
69/113Q 
1 18.6/1.17 84.6/1.75 69-113-69 5.5 
ABA-33/110P 2 15.1/1.25 47.9/1.33 33-110-33 0.0 
ABA-
21/117Q 
1 19.2/1.11 39.5/1.44 21-117-21 5.0 
ABA-
18/145Q 
1 23.6/1.15 40.5/1.26 18-145-18 5.0 
ABA-
37/192Q 
1 31.0/1.22 66.6/1.85 37-192-37 5.2 
a As determined by gel permeation chromatography (GPC) against polystyrene standards. 
b Calculated from GPC data before quarternization of the polymers. 
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Scheme 2.2 Reaction scheme representing the synthesis of RAFT-derived ABA tri-block 
copolymers by Hinton et al.28 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 As for the varying OEGMA block lengths, it was concluded that all of the A-blocks with 
at least 15 OEGMA repeat units and some DMAEMA composition were efficient at delivering the 
genetic material. The authors postulate that this increased positive charge from incorporating 
DMAEMA into the hydrophilic blocks aids in the condensing of the genetic material. The 
positively charged DMAEMA units of the A-block are attracted to the negatively charged nucleic 
acids in the core of the polyplex making the entire complex aggregate more than if there were no 
 33 
 
DMAEMA repeat units in the A-block; this attraction ultimately leads to better protection of the 
genetic material. In addition, the statistical copolymer being produced by the one pot method 
affords simplicity for the tri-block polymerization process since the intermediate purification step 
is not performed. Therefore, overall it was determined that an ABA triblock copolymer containing 
statistical A-blocks of hydrophilic and cationic content and a B-block of permanent positive charge 
yields the most efficient gene delivery vehicle.28   
 A study completed in a 2012 by Manganiello et al. analyzed the gene delivery efficiency 
of diblock copolymers composed of DMAEMA, 2-(diethylamino)ethyl methacrylate (DEAEMA), 
and butyl methacrylate (BMA). The DMAEMA macroCTA was synthesized and subsequently 
chain extended with various ratios of DEAEMA and BMA as shown in the reaction schematic in 
Scheme 2.3.  
Scheme 2.3 RAFT-mediated synthesis of a diblock copolymer consisting of a cationic 
poly(DMAEMA) block and an endosomolytic hydrophobic block incorporating DEAEMA and 
BMA at varying molar feed ratios from Manganiello et al.29 
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Unlike the previous studies utilizing DMAEMA for nucleic acid complexation, 
Manganiello utilized the DMAEMA block for polyplex formation as well as for hydrophilic 
stabilization as opposed to using a PEGylated monomer. The pH-responsive DEAEMA/BMA 
block was included for its endosomolytic activity. Like DMAMEA, DEAEMA also contains 
tertiary amine side chains capable of protonation in low pH environments; therefore, it can escape 
the endosomal pathway by the same mechanism. To deduce effects of added hydrophobic content 
to the endosomolytic block, the BMA percentages ranged from 20-70% in the B-block. These 
polymers having both cationic and hydrophobic content has a proposed endosomal escape 
mechanism in which the tertiary amine groups of DMAEMA and DEAEMA become protonated 
under decreasing pH conditions causing an increase in the positive charges of the polyplex core 
and corona. With DMAEMA being cationic as well, electrostatic repulsion will cause the polyplex 
to destabilize, therefore, releasing the genetic material. Additionally, increasing the hydrophobic 
content of the B-block causes the polyplex to be more stable since the hydrophobic moieties stay 
aggregated under aqueous conditions; therefore, by changing the DEAEMA to BMA ratio, the 
release mechanism could be optimized. After characterization experiments in vitro utilizing 
RAW264.7 and JAWSII cell lines, increasing transfection efficiency with decreasing BMA 
content was reported; however, this trend also holds true for cell toxicity with increasing toxicity 
for decreasing BMA content. Manganiello reported that copolymers containing 30-40% BMA 
content (60-70% DEAEMA) in the B-block exhibited the transition from inert to endosomolytic 
at those pH values expected in the endosome, providing the most promising gene delivery platform 
of the study.29 
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Scheme 2.4 RAFT-mediated synthesis of diblock copolymers consisting of a cationic 
poly(dimethylaminoethyl methacrylate) (DMAEMA, x=58) block and an endosomolytic 
polyampholyte block incorporating DMAEMA and propylacrylic acid (PAA) in equimolar ratios, 
and butyl methacrylate (BMA) (y~70) from Convertine et al.30 
 
 Similarly, in 2009 Convertine et al. reported on a copolymer family based on a comparable 
endosomal escape pathway to that of Manganiello.30 In this study, a DMAEMA macroCTA was 
chain extended with varying ratios of DMAEMA, BMA, and propylacrylic acid (PAA) (Scheme 
2.4). For the B-block, the feed ratios of DMAEMA and PAA were kept the same while the BMA 
content was varied. Again, DMAEMA is positively charged while BMA is hydrophobic. PAA, 
however, is negatively charged becoming protonated (less negatively charged) upon decreasing 
pH. Therefore, in the lower pH environments of the endosome, the PAA loses negative charge 
while the DMAEMA increases in positive charge, and by electrostatic repulsion among 
DMAEMA molecules, the polyplex is destabilized. The results of in vitro studies utilizing HeLa 
cells indicated that the polymer with the highest BMA content (50%) showed the highest level of 
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siRNA uptake. The cytotoxicity study indicated similar cell viability for all polymers analyzed in 
this study. As with Manganiello, Convertine et al. suspect a relationship between then BMA 
content of the endosomolytic block and the transfection efficiency of the copolymer.30 Here, 50% 
BMA content was concluded as most the efficient polymeric gene delivery vehicle while 
Manganiello reported 30-40%.29-30 The difference, however, can be explained by the different B-
block content and endosomal escape mechanism of the these two studies.   
 In 2013 Nelson et al. reported on the PEGylated copolymers of DMAEMA copolymerized 
with BMA.31 A linear PEG macroCTA was chain extended with various ratios of DMAEMA and 
BMA as illustrated in Scheme 2.5. The goal of this study was to identify a PEGylated gene delivery 
vehicle with an optimized B-block ratio of cationic and hydrophobic content. The previous studies, 
though analyzing the cation and hydrophobic ratios as well, did not include a PEGylated moiety 
for steric stability. From the studies in LR-3T3 and MDA-MB-231 cells, they noticed an inverse 
relationship between the BMA content in the polymer and the transitional pH of the micelles. The 
greater the BMA content, the lower the pH of the surrounding environment needed to be in order 
to induce the endosomolytic activity. This same trend was recognized and reported in both reports 
by Manganiello et al. and Convertine et al.29-30 The conclusion of the study by Nelson et al. was 
the copolymer containing 50% BMA has the optimum ratio of positive charge to hydrophobicity 
and efficiently delivers the genetic material to induce a biological response.31  
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Scheme 2.5 Polymer synthesis scheme for PEG-(DMAEMA-co-BMA) from Nelson et al.31 
 
Much research has been reported on the gene delivery efficacies of polymeric gene delivery 
vehicles. With the advent of CRP methods and RAFT polymerization in particular, it is now 
possible to synthesize polymers of well-defined molecular weights and architectures as well as 
biocompatible polymers containing hydrophilic segments for polyplex stability and toxicity 
control. Upon analysis of the previous works presented in this chapter, it is apparent that 
PEGylation of cationic polymers affords a biologically compatible copolymer ideal for gene 
delivery purposes. The addition of hydrophobic content in the cationic block of a copolymer has 
also been reported to increase the gene delivery efficacy. Interestingly, the variance of the cationic 
block without hydrophobic content is yet to be extensively studied or reported; therefore, it would 
be a worthwhile study to deduce the effects of cationic content and functionality on the gene 
delivery efficiency and cell toxicity.  
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CHAPTER 3 
RAFT POLYMERIZATION FOR THE SYNTHESIS OF TERTIARY AMINE-BASED 
DIBLOCK COPOLYMER NUCLEIC ACID DELIVERY VEHICLES 
 
3.1  Abstract 
A wide range of nucleic acid delivery vehicles have been studied for their efficacy in gene 
therapy, and with advances in controlled radical polymerization (CRP) techniques, the synthesis 
of precise polymeric architectures needed for these delivery vehicles is now possible. The 
development of a family of pH-responsive, diblock copolymers designed to effectively delivery 
genetic material is reported. The polymers were prepared by RAFT polymerization utilizing an 
oligo(ethylene glycol) methyl ether methacrylate (OEGMA) stabilizing block and a cationic block 
derived from a family of pH-responsive, tertiary amine-containing methacrylates, namely 2-
(dimethylamino) ethyl methacrylate (DMAEMA), 2-(diethylamino) ethyl methacrylate 
(DEAEMA), 2-(diisopropylamino) ethyl methacrylate (DPAEMA), capable of complexing with 
negatively charged nucleic acids. Nine copolymers were synthesized utilizing the same 
hydrophilic block length while varying the degree of polymerization of the cationic block to 
lengths of 25, 50, and 75 monomer units.  The polymers were characterized by gel permeation 
chromatography (GPC) to determine their molecular weight and polydispersity. To characterize 
the binding affinity of the siRNA/polymer complexes, electrophoresis and dynamic light scattering 
(DLS) experiments were carried out in various pH environments to mimic the pH values present 
in the early and late endosome. The diblock copolymers condensed siRNA at all N/P ratios at pH 
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5, while less binding affinity was observed with increasing pH. At all pH values, the polyplexes 
indicated particle sizes less than 25 nm in diameter, ideal for cell entry. In vitro studies utilizing 
HEK293 and MCF-7 cells were employed to evaluate cell toxicity and determine polymeric gene 
delivery efficiency. The cytotoxicity study indicates high cell viability with the diblock 
copolymers with the exception of E50 and E75 while the gene knockdown experiments indicated 
high siRNA delivery efficiency for all nine copolymers. As a result, this copolymer family will 
enable further studies and development for promising gene delivery vehicles capable for clinical 
use.  
 
3.2  Introduction 
 Since the emergence of gene therapy, a number of gene delivery vehicles have been 
characterized for their gene delivery efficacies.3, 10, 32-33 It has been reported from various studies 
that viral vectors indicate high toxicity and immunogenicity; therefore, the development of non-
viral vectors is crucial to the progression and clinical use of gene therapy.14-15, 33 Non-viral gene 
delivery vehicles such as cationic lipids and polymers have been extensively studied with reports 
of high transfection efficiencies; however, a number of these studies have failed during clinical 
trials.14-15 The challenges associated with utilizing non-viral vectors as gene delivery vehicles are 
mainly due to the lack of knowledge or understanding of their molecular interactions with cells 
and the overall gene delivery mechanism. Some known barriers to further developing polymeric 
gene delivery vehicles include cellular uptake, endosomal escape, and the efficient delivery of 
genetic material to the nucleus.14-15, 34 To overcome these challenges, pH-responsive polymers 
such as poly(ethyleneimine) (PEI) have been developed and studied for their ability to capitalize 
on the pH gradients of the endosomal pathway.35 Though PEI is known to have high efficiency of 
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polyplex formation as well as high gene expression, this polymer induces immunogenic responses 
both in vitro and in vivo because of it nonspecific interactions with various proteins and cells.14-15 
Moreover, there is a lack of control over the resulting molecular weight and architecture of PEI 
and other cationic polymers utilized for gene delivery vehicles.4, 36 These limitations of 
biocompatibility and polymerization control have stimulated further research and development of 
alternative polymeric gene delivery vehicles.  
 In order to improve the biocompatibility of cationic polymers for gene delivery, a 
hydrophilic component such as poly(ethylene glycol) (PEG) can be incorporated into the polymer 
design to afford stability in aqueous environments.3, 22-24, 31 A number of studies have discussed 
the positive effects of PEGylated copolymers on gene delivery efficiency with results including 
the decrease in immunogenicity and cellular toxicity and overall improvement in the polyplex 
stability in vitro.22-24 Studies such as those by Deshpande et al. and Venkataraman et al. have 
reported that varying the PEG architecture has an effect on the delivery efficiency of genetic 
material and indicate that a block copolymer structure has better delivery efficiency than that of a 
statistical copolymer.22-24 
With the advent of controlled radical polymerization (CRP) techniques, reversible 
addition-fragmentation chain transfer (RAFT) polymerization in particular, the synthesis of well-
defined molecular weight polymers with low polydispersity is now possible.1-2 One significant 
adaptation of RAFT polymerization is the advancement in the ability to produce water-soluble, 
functional polymers that are inherently biocompatible, ideal for the development of gene delivery 
vehicles.3-4, 10 Many studies have reported on the use of tertiary amine-containing monomers for 
use as the cationic building blocks for gene delivery vehicles. Of these, DMAEMA has been the 
most extensively studied since the first reports of CRP and RAFT polymerization due to its high 
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transfection efficiency and endosomal destabilizing properties.25-27, 37 A number of studies have 
elucidated the effects of PEGylated DMAEMA polymers with incorporated hydrophobic content 
as effective gene delivery vehicles.28, 31 The role of tertiary amine functionality alone on the nucleic 
acid delivery efficiency has yet to be discussed. 
Here, we report on the biological efficacy of a series of diblock copolymer gene delivery 
vehicles. Utilizing RAFT polymerization to ensure the controlled synthesis of well-defined block 
copolymers with narrow PDIs, we designed and synthesized a family of tertiary amine-based 
PEGylated copolymers incorporating oligo(ethylene glycol) methyl ether methacrylate (OEGMA) 
to promote biocompatibility as well as colloidal stability and 2-(dimethylamino) ethyl 
methacrylate (DMAEMA), 2-(diethylamino) ethyl methacrylate (DEAEMA), or 2-
(diisopropylamino) ethyl methacrylate (DPAEMA) for nucleic acid complexation and endosomal 
escape. To examine the effects of cationic functional groups and block length on gene delivery 
efficiency, nine diblock copolymers were synthesized with varying degrees of polymerization in 
order to analyze and elucidate the effects of different cationic moieties on polyplex formation and 
in vitro delivery.  
 
3.3 Experimental Procedures 
 
3.3.1  Materials 
All chemicals were purchased from Sigma-Aldrich at the highest available purity and used 
as received unless otherwise noted. OEGMA (Mn = 475 g/mol), DMAEMA, DEAEMA, 
DPAEMA were passed through a column of basic alumina to remove inhibitor prior to 
polymerization. 
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3.3.2 Polymer Synthesis  
Utilizing RAFT polymerization, a solution of OEGMA (59.4 g, 125 mmol), 4-cyano-4-
[(dodecylsulfanylthiocarbonyl)sulfanyl] pentanoic acid (CDP) (1.01 g, 2.5 mmol), and 4,4’-
azobis(4-cyanovaleric acid) (V-501) (140 mg, 0.5 mmol) in 445 mL DMSO were added to a 1000 
mL round bottom flask fitted with a rubber stopper. This solution was sparged with nitrogen for 
30 minutes and placed in a 70°C preheated oil bath. The polymerization was allowed to proceed 
for 2 hours prior to termination by exposure to air. The resulting polymer was purified by dialysis 
against water for 3 days and then subsequently recovered by lyophilization.  
The resulting OEGMA macroCTA was chain extended with DMAEMA (pKa 7.4), 
DEAEMA (pKa 7.2), or DPAEMA (pKa 6.9) to form the desired block copolymers. For all block 
copolymerizations, the [M]ₒ/[CTA]ₒ and [CTA]ₒ/[I]ₒ were 125:1 and 10:1 respectively. As an 
example, a solution of DMAEMA (2.36 g, 15 mmol), pOEGMA macroCTA (2.2 g), and V-501 
(3.4 mg, 0.012 mmol) in 12.5 mL of DMF was added to a 40 mL glass reaction vial fitted with a 
septa cap. The solutions were sparged with nitrogen for 20 minutes prior to polymerization in a 
70°C preheated Thermo Scientific MaxQ 2000 Shaker coupled with a J-KEM temperature 
controller. The polymerization was allowed to proceed for 2.75 hours prior to termination by 
exposure to air. The resulting diblock copolymer, p(OEGMA-b-DMAEMA), was purified by 
dialysis against DI water for three days prior to lyophilization.  
 
3.3.3 Polymer Characterization 
Gel permeation chromatography (GPC) was used to determine the number-average 
molecular weight (Mn) and polydispersity indices (PDIs) of the diblock copolymers. Utilizing a 
Thermo Scientific Dionex pump (UltiMate 3000 Pump) and paired autosampler (UltiMate 3000 
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Autosampler Column Compartment), an aqueous eluent of 1 wt% acetic acid/ 0.10 M Na2SO4 (aq) 
at a flow rate of 0.25 mL/min was employed. Eprogen Inc. columns [CATSEC 1000 (7 μ, 50 x 
4.6), CATSEC 100 (5 μ, 250 x 4.6), and two CATSEC 300 (5 μ, 250 x 4.6)] connected in series 
were coupled with a Wyatt miniDAWN TREOS multi-angle light scattering detector (λ = 690 nm) 
and a Wyatt Optilab t-REX differential refractive index (dRI) detector (λ = 690 nm). The dn/dc of 
each homopolymer was measured utilizing the Wyatt Optilab t-REX; dn/dc values were 
implemented into the Wyatt Technology ASTRA software calculations for absolute molecular 
weight determination.   
 
3.3.4 siRNA/Copolymer Complex Characterization 
To verify the stable siRNA/polymer complexation, agarose gel electrophoresis was 
utilized. A 46 nucleotide, single-stranded oligonucleotide comprised of the NHE III1 region of the 
MYC promoter and labeled with the fluorescent dye Fluorescein (6-FAM) (0.25 μM, sequence: 
5’-GCGCTTATGGGGAGGGTGGGGAGGGTGGGGAAGGTGGGGAGGAGAC-3’) was 
mixed with aqueous solutions of the diblock copolymers in Tris-Acetate EDTA (TAE) buffer at 
pH values of 5,7, or 9. The theoretical charge ratio of the nitrogen in the polymers to phosphorous 
in the nucleic acids (N/P) were calculated using the positively charged cationic blocks of 
DMAEMA, DEAEMA, or DPAEMA and the negatively charged siRNA. N/P ratios ranging from 
0 to 7 were utilized. The copolymer/siRNA mixtures were allowed to incubate for 30 minutes at 
room temperature to allow for polyplex formation before 3μL of 50% glycerol and 1 μL of 6x 
DNA loading dye were added. The polyplex samples were then loaded on 1% agarose gels with 
1x GelGreen dye (Phenix Research, Candler, NC) made with TAE buffers at the same pH as 
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incubation. Gels were subjected to 70V for 30 minutes before transillumination imaging on a 
FotoDyne gel imager.  
The size of the siRNA/copolymer complexes were characterized in varying pH solutions 
by dynamic light scattering (DLS) utilizing a Malvern Zetasizer Nano ZS  (Malvern Instruments 
Ltd., Max 4 mW He-Ne laser, incident beam λ=633 nm) and accompanying Zetasizer Software. 
Briefly, copolymers were incubated in water (pH 5, 7, and 9) with appropriate amounts of 6-FAM 
(0.3 μM) at an N/P ratio of 3. Copolymers were allowed to condense the siRNA for 30 minutes at 
room temperature before running measurements in triplet.   
 
3.3.5  Cellular Uptake 
 To initially determine if this copolymer series was capable of cellular transfection, the 
polymer/siRNA complexes were incubated with human embryonic kidney cells (HEK293) 
maintained in a 37°C humid atmosphere containing 5% CO2. To measure the cellular uptake, cells 
were seeded in 12-well plates at a concentration of 1 x 105 cells per well in 1 mL of media. The 
cells were allowed to incubate overnight before addition of polymer/siRNA complexes. The next 
day, polyplexes at an N/P ratio of 3 were prepared utilizing a 19-mer fluorescein-labeled scramble 
siRNA (0.545 μM, Cell Signaling Technology) and the appropriate amounts of copolymer solution 
and the reduced serum media Opti-MEM (GIBCO). The mixture was subsequently allowed to 
incubate at room temperature for 30 minutes. Additionally, the siRNA was incubated at room 
temperature with 1.2 μL of Fugene (Promega). The polyplexes and Fugene/siRNA complexes 
were then added to the wells and allowed to incubate for 24 hours. The next day the media was 
discarded and replaced to rid any free polymer or siRNA. The efficiency of the copolymer 
mediated gene delivery was then qualitatively determined with use of a fluorescent enabled 
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microscope by visualizing the fluorescence of the Fluorescein labeled siRNA that was successfully 
delivered to the cells.  
 
3.3.6 Cell Viability Assay 
MCF-7 cells were seeded in 96-well plates at a concentration of 7.5 × 103 cells per well in 
90 μL of media and were allowed to attach overnight. The following day, a 10x stock plate of 
polyplex solutions diluted from 5 mM over a 5-6 log range in 0.5 log steps was made, and 10 μL 
of this stock was added to the cell plate, in triplicate. The final high dose range was 0.08 – 500 
μM. Cell-free wells with the same dose-range were plated, and served as measurements of 
background absorption. 48 hr later, 20 μL of MTS + 5% PMS was added to each well and incubated 
for ~2 hr before the absorption at 490 nm was measured on a BioTek Synergy 2 plate reader 
(Winooski, VT). Background absorptions were subtracted, and data were normalized to control 
cells to determine any changes in cell viability. 
 
3.3.7 MYC Knockdown Studies 
MCF-7 breast cancer cells were obtained fresh from ATCC (Manassa, VA) and were 
maintained in exponential growth in Dulbecco’s minimal essential medium (DMEM) that was 
supplemented with 10% fetal bovine serum and 1x penicillin/streptomycin solution in a 37°C 
humid atmosphere containing 5% CO2. To measure cellular uptake, cells were seeded in two 12-
well plates at a concentration of 8 x 104 cells per well in 0.5 mL of media and allowed to attach 
overnight. The following day, polyplexes were prepared as previously described with a 19-mer 
MYC siRNA (Cell Signaling Technology, #6341) at an N/P ratio of 3. In addition, the siRNA was 
complexed with 1.2 μL of Fugene HD (Promega) and incubated for 30 minutes at room 
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temperature. The polyplexes were added to the wells and allowed to incubate for 48 hr. After the 
48 hour period, the wells were rinsed with water, and the cells were collected by lysis buffer. After 
subsequent β-mercaptoethanol (BME) addition, all samples were frozen for future analysis.  
 Once samples were thawed, the RNA was extracted with the use of a Roche GeneJET kit 
(Roche, Basel, Switzerland) according to the kit directions. The yield and purity of the RNA was 
determined with the use of a NanoDrop-1000 (NanoDrop); only samples with 260/230 values 
greater than 1.5 were considered pure enough for continued use. 500 ng of RNA was reverse 
transcribed into cDNA using the BioRad iScript kit according to the directions using a BioRad 
Thermocycler. Quantitative polymerase chain reaction (qPCR) was run on the cDNA samples 
using TaqMan primers (ABI). In particular, 5 μL of cDNA was evaluated by multiplexing FAM-
labeled MYC primers (Life Technologies, Hs00153408_m1) with VIC-labeled GAPDH primers 
(Life Technologies, catalog number 4326317E) using SsoAdvanced PCR Mix (BioRad) on a CFX 
Connect qPCR machine (BioRad). Changes in RNA expression were determined by the Cq 
method. 
 
3.4 Results and Discussion 
 
3.4.1 Polymer Synthesis  
RAFT polymerization enabled the synthesis of well-defined AB diblock copolymers for 
nucleic acid delivery. The pH-responsive diblock copolymers were synthesized according to 
Scheme 3.1. The RAFT polymerization of OEGMA was initiated by V-501 and mediated by CDP 
in DMSO. After purification, the OEGMA macroCTA was chain-extended with one of three 
tertiary amine monomers, DMAEMA, DEAEMA, or DPAEMA, to yield a series of diblock 
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copolymers with a permanently hydrophilic A block to impart water-solubility and provide steric 
hindrance to aggregation and varying lengths of pH-responsive B blocks for nucleic acid 
complexation. The degrees of polymerization of 25, 50, and 75 were targeted for the pH-responsive 
B block in order to investigate the effect of the repeat unit structure and block length of the cationic 
block on the delivery of nucleic acid payloads.  
 
Scheme 3.1. RAFT polymerization of OEGMA and subsequent chain extension with tertiary 
amine-containing monomers to form pH-responsive diblock copolymers for siRNA delivery. 
 
3.4.2 Polymer Characterization 
RAFT polymerization proved to be an effective methodology for controlling the degrees 
of polymerization of the diblock copolymers while maintaining a low polydispersity index (< 1.1) 
as shown in Table 3.1. To prove the successful chain extension of the OEGMA macroCTA, GPC 
chromatograms of the macroCTA and P75 are depicted in Figure 3.1. P75 has a shorter elution 
time as compared to the OEGMA macroCTA; therefore, P75 has a larger molecular weight 
indicating the desired chain extension of the macroCTA and successful synthesis of amphiphilic 
diblock copolymers. The slight tail observed with the P75 chromatogram can be attributed to a 
small percentage of dead macroCTA polymer chains not capable of chain extension.  
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Table 3.1. Molecular weight data for the pH-responsive diblock copolymer series. 
 Polymer 
Mn 
(g/mol) 
PDI 
p(OEGMA38-b-DMAEMA27) M25 22,900 1.02 
p(OEGMA38-b-DMAEMA51) M50 26,800 1.02 
p(OEGMA38-b-DMAEMA76) M75 30,800 1.01 
p(OEGMA38-b-DEAEMA29) E25 24,400 1.03 
p(OEGMA38-b-DEAEMA50) E50 28,800 1.05 
p(OEGMA38-b-DEAEMA73) E75 33,900 1.04 
p(OEGMA38-b-DPAEMA29) P25 26,600 1.04 
p(OEGMA38-b-DPAEMA53) P50 32,800 1.04 
p(OEGMA38-b-DPAEMA74) P75 38,300 1.02 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. GPC chromatogram indicating the successful chain extension of the OEGMA 
macroCTA with DPAEMA. The P75 copolymer has a shorter elution time from the GPC columns 
indicating that it has a larger molecular weight than the macroCTA. 
 
3.4.3 siRNA/Copolymer Characterization 
The ability of the pH-responsive diblock copolymers to bind with nucleic acids was 
assessed via electrophoretic gel shift assays. The three protonatable tertiary amine-contianing B-
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blocks have pKa values varying from 6.9 for DPAEMA to 7.4 for DMAEMA. We tested the 
nucleic acid binding abilty of the diblock copolymers at pH values of 5, 7, and 9 to examine the 
pH effect on the binding affinity of the diblock copolymers. Figure 3.2 shows a representative 
series of gel shift assays for the diblock copolymers with a targeted B block degree of 
polymerizaiton of 50.  
 
 
Figure 3.2 Gel shift assays for the diblock copolymers M50, E50, and P50. pH values of 5, 7, and 
9 with N/P ratios ranging from 0 (no polymer added) to 7 were utilized. The percent of the B block 
moieties protonated is shown for each gel shift experiment.  
 
At a pH of 5 where ~ 99% of the tertiary amine moieties are protonated, M50, E50, and 
P50 bind DNA at the low N/P ratio of 1 indicted by the fluorescent signal remaning in the wells. 
The somewhat low florescense signal for all samples at pH 5 can be explained by the reported 
effect of low pH environments on the fluoresnce of molecules including Fluroroscein38. If the pH 
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value of the buffer is increased to 7, the percentage of protonated tertiary amine moieties decreases, 
but has only a minimal effect, if any, on the nucleic acid binding. As the pH of the buffer is further 
increased to a value of 9, the tertiary amine groups become mostly deprotonated (>98%) and has 
a dramatic effect on the ability of the diblock copolymers to complex with nucleic acids. For all 
diblock copolymers tested at pH 9, minimal NA binding was observed for all tested N/P ratios 0 
to 7. 
To further characterize the siRNA/copolymer, DLS was employed to analyze the pH-
dependent nature of the copolymers by determining the polyplex size at varying pH. Utilizing a 
theoretical charge ratio of 3:1, the polymers and nucleic acid material were allowed to incubate in 
water at pH 5, 7, and 9 before DLS measurements. From this characterization, it was determined 
that the polyplex diameter at pH 5, 7, and 9 for all copolymers investigated was less than 25 nm 
making them ideal for cellular uptake. As an example, Figure 3.3 illustrates the DLS data for M50 
complexed with siRNA in water at pH 5, 7, and 9. A shift to larger diameters with increasing pH 
is expected and observed. When not complexed with genetic material, the pKa of DMAEMA is 
7.4. At the lower pH, therefore, the vast majority of the tertiary amines would be protonated 
causing the siRNA/polymer complexes to be more tightly bound. This strong binding affinity is 
indicated by the smaller diameter in the pH 5 solution. The polyplex size then increases with 
increasing pH since less of the tertiary amine side chains will be protonated. This decrease in 
positively charged moieties causes the polyplex to have less molecular interactions with the nucleic 
acids which in turn causes the polyplex to swell indicated by the larger particle size.  
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Figure 3.3 DLS measurements of M50 characterizing the pH-responsive nature of the tertiary 
amine-based polymers. The data shows that for increasing pH, the polyplex diameter increases as 
well indicating the pH dependent behavior of this diblock copolymer family.  
 
3.4.4 siRNA/Copolymer Cellular Uptake  
The ability of the copolymers to deliver genetic material to cells at an N/P ratio of 3 was 
determined by the in vitro experiments utilizing the HEK293 cell line. This in vitro study was 
utilized to gain preliminary results of the polymer-mediated gene delivery efficiency in order 
determine if the copolymer series should be further pursued with more mature studies and 
experimentation. The polymers were incubated with the siRNA for thirty minutes to allow for 
polyplex formation before being added to the cell culture to incubate for 24 hours. After this period, 
the fluorescent levels of fluorescein were qualitatively evaluated utilizing a fluorescent enabled 
microscope. The images collected from this copolymer mediated cellular uptake study are shown 
in Figure 3.4 along with the two controls of siRNA only and Fugene mediated delivery. Overall, 
we noticed some degree of fluorescence with all nine cultures indicative of successful polymeric 
nucleic acid delivery; however, E50, P50, and P75 visually appear to have delivered the highest 
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concentration of the nucleic acid material, as indicated by the stronger fluorescence signal. Though 
further investigations would be required, we know this copolymer series is capable of effectively 
delivering genetic material to HEK293 cells.   
 
 
Figure 3.4 In vitro study utilizing HEK293 cell line to determine the cellular update ability of the 
siRNA/copolymer complexes with a fluorescing signal indicating effective gene delivery.  
 
 
3.4.5 Copolymer Toxicity 
 In order to evaluate the effect of the tertiary amine functionalities and cationic block length 
on cell viability, the copolymers were analyzed for their ability to induce an immunogenic 
response. To investigate these cytotoxic effects, the copolymers were incubated with MCF-7 cells 
for 48 hours after which time MTS viability assays were utilized for characterization. The resulting 
cell viability after the subtraction of background absorption and data normalization to the control 
is shown in Figure 3.5. High levels of cell viability (>90% after 48 hr) were observed for all 
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copolymers tested with the exception of E50 and E75 which indicate high levels of toxicity (<50% 
cell viability). Here, the addition of the hydrophilic block did not significantly affect the toxicity 
levels of E50 and E75 as expected.  
 
Figure 3.5 Cytotoxicity study of the copolymer series. Most polymers were nontoxic with the 
exception of E50 and E75 proving to be significantly toxic to the cell line.  
 
 
 
3.4.6  Polyplex-Mediated Gene Knockdown 
 In order to investigate the ability of the copolymers to effectively deliver genetic material 
to the nucleus, gene knockdown experiments in MCF-7 cells were employed utilizing the polyplex 
N/P ratio of 3:1. The siRNA/polymer complexes were incubated with the MCF-7 cells for 48 
hours. After this time, MYC expression was evaluated and normalized to GAPDH with the 
resulting data illustrated in Figure 3.5. All polymers with the exception of P75 express a significant 
decrease in the MYC expression as compared to that of FuGene; therefore, the block polymers 
indicate potential for successful gene delivery vehicles.  Interestingly, there is not an apparent 
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trend for the different tertiary amine functional groups or degrees of polymerization; however, 
there are differences among each respective series. Among all polymers, a significant difference 
in the MYC knockdown is not observed so one block copolymer cannot be named superior over 
the others studied.  
 As reported, E50 and E75 induce a toxic response in MCF-7 cells resulting in low cell 
viability. Though they induce this cytotoxic activity, these two block copolymers are still capable 
of gene knockdown. This experiment was designed to normalize the inputs as well as the results 
in order to take cell death into consideration. Normalizations included the cDNA input, the MYC 
to GAPDH expression, and the polymer treatments to the control. Figure 3.5, therefore, indicates 
that E50 and E75 are plausible candidates for a viable gene delivery vehicle despite their toxic 
effect.  
 
 
Figure 3.5 qPCR results indicating a significant decrease in the MYC expression for the 
copolymers as compared to FuGene with the exception of P75.   
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3.5 Conclusions 
 The advent of RAFT polymerization offers many advantages to the synthesis of 
biologically compatible block copolymers in that well-defined molecular weight and architectures 
are now possible. The use of this polymerization method has brought many advances to the 
potential use of gene-based therapies in a clinical setting. Here, we have reported on the 
development of a novel, diblock copolymer series capable of condensing genetic material and 
escaping the endosome by means of a pH-responsive endosomolytic block. These copolymers 
were synthesized with a biocompatible A-block composed of OEGMA and a cationic B-block of 
DMAEMA, DEAEMA, or DPAEMA with the aim to separate out the effects of repeat unit 
structure and block length of the cationic block on the efficiency of nucleic acid delivery.  The 
results determined from this study indicate a link between cationic block length and repeat unit 
structure on the gene delivery efficacy. Pairing the low toxicity and effectiveness, this copolymer 
family will enable further studies and development for promising gene delivery vehicles capable 
for clinical use.  
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CHAPTER 4 
FUTURE DIRECTIONS 
 From our studies, we have successfully developed an efficient nucleic acid delivery vehicle 
that exhibits high cell viability and cell transfection. Moving forward, we hope to further 
investigate these pH-responsive block copolymers by characterizing their affinity and delivery 
efficiency of a G-quadruplex (G4) clamp as developed by the research team led by Tracy Brooks. 
It has been reported that G-quadruplexes appear in the promoter region of the MYC oncogene, and 
their stabilization leads to downregulation of MYC expression.39 The G4 clamp is composed of 
complementary sequences to flank either side of the G-quadruplex of the promoter region held 
together by a linker sequence. Once this G4 clamp is bound, the quadruplex is stabilized and gene 
expression decreases. Should the copolymers presented in this study effectively deliver this G-
quadruplex clamp, we can stabilize the quadruplex and cease MYC expression.   
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